Saïda Aarrass

466 total citations
14 papers, 368 citations indexed

About

Saïda Aarrass is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Saïda Aarrass has authored 14 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Rheumatology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Saïda Aarrass's work include Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). Saïda Aarrass is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). Saïda Aarrass collaborates with scholars based in Netherlands, United Kingdom and United States. Saïda Aarrass's co-authors include Maria C. Lebre, Paul P. Tak, Man Tang, Dennis van der Coelen, Lisa G. M. van Baarsen, Daniëlle M. Gerlag, Massimo Pinzani, Piter J. Bosma, Ronald P.J. Oude Elferink and W. Boers and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Saïda Aarrass

14 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saïda Aarrass Netherlands 7 174 138 88 70 52 14 368
Yuxing Shan China 9 246 1.4× 198 1.4× 93 1.1× 86 1.2× 53 1.0× 11 478
Taichiro Miyashita Japan 12 172 1.0× 163 1.2× 141 1.6× 40 0.6× 38 0.7× 24 440
Lucyna Korman Poland 12 163 0.9× 213 1.5× 48 0.5× 64 0.9× 65 1.3× 27 404
Olfa Abida Tunisia 14 180 1.0× 173 1.3× 73 0.8× 31 0.4× 31 0.6× 46 435
Pilar Bravo Spain 11 228 1.3× 66 0.5× 29 0.3× 63 0.9× 60 1.2× 14 371
Esperanza Ávalos-Díaz Mexico 13 221 1.3× 285 2.1× 121 1.4× 49 0.7× 32 0.6× 54 553
B. Sean Carey United Kingdom 9 278 1.6× 54 0.4× 79 0.9× 40 0.6× 39 0.8× 20 507
Huaqun Zhu China 11 322 1.9× 131 0.9× 89 1.0× 72 1.0× 40 0.8× 23 463
Jieyue Liao China 8 178 1.0× 137 1.0× 147 1.7× 53 0.8× 13 0.3× 17 421
Siobhan Wade Ireland 10 228 1.3× 194 1.4× 209 2.4× 87 1.2× 97 1.9× 10 509

Countries citing papers authored by Saïda Aarrass

Since Specialization
Citations

This map shows the geographic impact of Saïda Aarrass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saïda Aarrass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saïda Aarrass more than expected).

Fields of papers citing papers by Saïda Aarrass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saïda Aarrass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saïda Aarrass. The network helps show where Saïda Aarrass may publish in the future.

Co-authorship network of co-authors of Saïda Aarrass

This figure shows the co-authorship network connecting the top 25 collaborators of Saïda Aarrass. A scholar is included among the top collaborators of Saïda Aarrass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saïda Aarrass. Saïda Aarrass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kuijk, Arno W. van, Marcel B. M. Teunissen, Dennis van der Coelen, et al.. (2022). Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis. Biomedicines. 10(2). 324–324. 5 indexed citations
2.
Ramos, M Inês Pascoal, Samuel García, Boy Helder, et al.. (2020). cDC1 are required for the initiation of collagen-induced arthritis. SHILAP Revista de lepidopterología. 3. 100066–100066. 4 indexed citations
3.
Ramos, M Inês Pascoal, Marcel B. M. Teunissen, Boy Helder, et al.. (2016). Reduced CLEC9A expression in synovial tissue of psoriatic arthritis patients after adalimumab therapy. Lara D. Veeken. 55(9). 1575–1584. 7 indexed citations
4.
Lebre, Maria C., Pedro L. Vieira, Man Tang, et al.. (2016). Synovial IL-21/TNF-producing CD4+ T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes. Journal of Leukocyte Biology. 101(3). 775–783. 33 indexed citations
5.
Baarsen, Lisa G. M. van, Maria C. Lebre, Dennis van der Coelen, et al.. (2014). Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?. Arthritis Research & Therapy. 16(4). 426–426. 121 indexed citations
6.
Lebre, Maria C., Pedro L. Vieira, Saïda Aarrass, et al.. (2014). A8.9 Rheumatoid arthritis synovial IL-21 + CD4+ t cells specifically induce matrix metalloproteinase production by fibroblast-like synoviocytes. Annals of the Rheumatic Diseases. 73. A79–A79. 3 indexed citations
7.
Ramos, M Inês Pascoal, Samuel García, Wolfgang Baum, et al.. (2014). A8.19 Non-lymphoid CD103+ dendritic cells are required for the initiation of collagen-induced arthritis. Annals of the Rheumatic Diseases. 73. A83–A84. 1 indexed citations
8.
Ramos, M Inês Pascoal, et al.. (2013). Absence of Fms-like tyrosine kinase 3 ligand (Flt3L) signalling protects against collagen-induced arthritis. Annals of the Rheumatic Diseases. 74(1). 211–219. 12 indexed citations
9.
Lebre, Maria C., Pedro L. Vieira, Saïda Aarrass, et al.. (2013). A3.16 Specific Overexpression of Synovial Interleukin-21+ CD4+ T Cells Co-Expressing Tumour Necrosis Factor in Rheumatoid Arthritis: Role in Joint Destruction?. Annals of the Rheumatic Diseases. 72. A19–A19. 1 indexed citations
10.
Ramos, M Inês Pascoal, Saïda Aarrass, Sten Eirik W. Jacobsen, Paul P. Tak, & Maria C. Lebre. (2013). A9.4 Flt3L-Dependent CD103+ DC are Crucial for the Initiation and Maintenance of Collagen-Induced Arthritis. Annals of the Rheumatic Diseases. 72. A65–A66. 1 indexed citations
11.
Ramos, M Inês Pascoal, Samuel García, Saïda Aarrass, et al.. (2013). FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis. Arthritis Research & Therapy. 15(6). R209–R209. 23 indexed citations
12.
Lebre, Maria C., Clarissa E. Vergunst, Ivy Y. Choi, et al.. (2011). Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis. PLoS ONE. 6(7). e21772–e21772. 65 indexed citations
13.
Vieira, Pedro L., Maria C. Lebre, Saïda Aarrass, et al.. (2010). Expansions of interleukin 21-secreting CD4 T helper cells in inflammatory arthritides. Annals of the Rheumatic Diseases. 69. A68–A68. 1 indexed citations
14.
Boers, W., et al.. (2006). Transcriptional Profiling Reveals Novel Markers of Liver Fibrogenesis. Journal of Biological Chemistry. 281(24). 16289–16295. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026